BCMU
OPTR

BlueCrest Capital Management (UK)’s OPTIMER PHARMACEUTICALS, INC. COM STK OPTR Stock Holding History

BlueCrest Capital Management (UK)’s Portfolio OPTR Stock Details OPTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-130,263
Closed -$1.64M – 534
2013
Q3 		$1.64M Buy
+130,263
New +$1.73M 0.08% 155

BlueCrest Capital Management (UK)'s OPTR Position: Q4 2013 in Review

BlueCrest Capital Management (UK) sold out of OPTIMER PHARMACEUTICALS, INC. COM STK (OPTR) in Q4 2013, closing a stake of 130,263 shares — an estimated $1.64M sold.

BlueCrest Capital Management (UK) first reported a position in OPTR in Q3 2013 and held it in 1 quarter. The position peaked at $1.64M in Q3 2013. 0 funds tracked by Wall St. Rank hold OPTR as of Q4 2013.

  • BlueCrest Capital Management (UK) reported no remaining OPTIMER PHARMACEUTICALS, INC. COM STK position as of Q4 2013 after selling out during the quarter.
  • BlueCrest Capital Management (UK) sold 130,263 OPTIMER PHARMACEUTICALS, INC. COM STK shares in Q4 2013, an estimated $1.64M.
  • BlueCrest Capital Management (UK) first reported a position in OPTIMER PHARMACEUTICALS, INC. COM STK in Q3 2013 and held it in 1 quarter.
  • BlueCrest Capital Management (UK)'s OPTIMER PHARMACEUTICALS, INC. COM STK position peaked at $1.64M in Q3 2013.
  • 0 funds tracked by Wall St. Rank held OPTIMER PHARMACEUTICALS, INC. COM STK as of Q4 2013.

Based on BlueCrest Capital Management (UK)'s 13F filing for Q4 2013, filed 14 Feb 2014.